000			02244 a2200637 4500
005			20250515105730.0
264		0	_c20081030
008			200810s 0 0 eng d
022			_a1440-1746
024	7		_a10.1111/j.1440-1746.2008.05319.x _2doi
040			_aNLM _beng _cNLM
100	1		_aFurusyo, Norihiro
245	0	0	_aAssociation between the treatment length and cumulative dose of pegylated interferon alpha-2b plus ribavirin and their effectiveness as a combination treatment for Japanese chronic hepatitis C patients: project of the Kyushu University Liver Disease Study Group. _h[electronic resource]
260			_bJournal of gastroenterology and hepatology _cJul 2008
300			_a1094-104 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Multicenter Study
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntiviral Agents _xadministration & dosage
650	0	4	_aAsian People
650	0	4	_aDrug Administration Schedule
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aGenotype
650	0	4	_aHepacivirus _xgenetics
650	0	4	_aHepatitis C, Chronic _xdiagnosis
650	0	4	_aHumans
650	0	4	_aInterferon alpha-2
650	0	4	_aInterferon-alpha _xadministration & dosage
650	0	4	_aJapan
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPolyethylene Glycols
650	0	4	_aProspective Studies
650	0	4	_aRNA, Viral _xblood
650	0	4	_aRecombinant Proteins
650	0	4	_aRibavirin _xadministration & dosage
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
650	0	4	_aViral Load
700	1		_aKajiwara, Eiji
700	1		_aTakahashi, Kazuhiro
700	1		_aNomura, Hideyuki
700	1		_aTanabe, Yuichi
700	1		_aMasumoto, Akihide
700	1		_aMaruyama, Toshihiro
700	1		_aNakamuta, Makoto
700	1		_aEnjoji, Munechika
700	1		_aAzuma, Koichi
700	1		_aShimono, Junya
700	1		_aSakai, Hironori
700	1		_aShimoda, Shinji
700	1		_aHayashi, Jun
773	0		_tJournal of gastroenterology and hepatology _gvol. 23 _gno. 7 Pt 1 _gp. 1094-104
856	4	0	_uhttps://doi.org/10.1111/j.1440-1746.2008.05319.x _zAvailable from publisher's website
999			_c17754212 _d17754212